Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7482422
Reference Type
Journal Article
Title
Malignant Mesothelioma: Pathology
Author(s)
Anttila, S; ,
Year
2020
Publisher
Springer International Publishing
Location
Cham
Book Title
Occupational Cancers
Page Numbers
303-318
Language
English
DOI
10.1007/978-3-030-30766-0_17
URL
http://link.springer.com/10.1007/978-3-030-30766-0_17
Exit
Abstract
The majority of malignant mesotheliomas (MMs) occur in the pleura, but they may also arise in the peritoneum, the pericardium, or the tunica vaginalis testis. MM is a great mimic and its morphology is so variable that a vast number of different primary and secondary tumors of the body cavities must be considered in differential diagnosis. Another diagnostic challenge is distinguishing MM from reactive lesions, i.e., epithelioid MM from benign mesothelial hyperplasia and sarcomatoid or desmoplastic MM from fibrous pleuritis. Molecular markers, such as loss of BAP1 and homozygous deletion of 9p21 chromosomal region, have a specificity of 100% and, if combined, a sensitivity of appr. 80% in the diagnosis of malignant mesothelioma. Diffuse MM exhibiting any subtype or morphological pattern may have asbestos etiology. © Springer Nature Switzerland AG 2020.
Keywords
Cytology; Immunohistochemistry; Malignant mesothelioma; Mesothelioma diagnosis; Mesothelioma subtypes; Pathology
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity